270 related articles for article (PubMed ID: 30902882)
1. LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression.
Zhou Q; Zhan H; Lin F; Liu Y; Yang K; Gao Q; Ding M; Liu Y; Huang W; Cai Z
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30902882
[TBL] [Abstract][Full Text] [Related]
2. LincRNA-p21 suppresses development of human prostate cancer through inhibition of PKM2.
Wang X; Xu Y; Wang X; Jiang C; Han S; Dong K; Shen M; Xu D
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28994148
[TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.
Xiang Y; Stine ZE; Xia J; Lu Y; O'Connor RS; Altman BJ; Hsieh AL; Gouw AM; Thomas AG; Gao P; Sun L; Song L; Yan B; Slusher BS; Zhuo J; Ooi LL; Lee CG; Mancuso A; McCallion AS; Le A; Milone MC; Rayport S; Felsher DW; Dang CV
J Clin Invest; 2015 Jun; 125(6):2293-306. PubMed ID: 25915584
[TBL] [Abstract][Full Text] [Related]
4. miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
Luan W; Zhou Z; Zhu Y; Xia Y; Wang J; Xu B
Biochem Biophys Res Commun; 2018 Jan; 495(1):46-52. PubMed ID: 29097210
[TBL] [Abstract][Full Text] [Related]
5. Long intragenic non-coding RNA lincRNA-p21 suppresses development of human prostate cancer.
Wang X; Ruan Y; Wang X; Zhao W; Jiang Q; Jiang C; Zhao Y; Xu Y; Sun F; Zhu Y; Xia S; Xu D
Cell Prolif; 2017 Apr; 50(2):. PubMed ID: 27976428
[TBL] [Abstract][Full Text] [Related]
6. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
[TBL] [Abstract][Full Text] [Related]
7. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
8. LincRNA-p21 enhances the sensitivity of radiotherapy for gastric cancer by targeting the β-catenin signaling pathway.
Chen L; Yuan D; Yang Y; Ren M
J Cell Biochem; 2019 Apr; 120(4):6178-6187. PubMed ID: 30484893
[TBL] [Abstract][Full Text] [Related]
9. Long intergenic noncoding RNA-p21 inhibits apoptosis by decreasing PUMA expression in non-small cell lung cancer.
Yang T; Zhang W; Wang L; Xiao C; Guo B; Gong Y; Liang X; Huang D; Li Q; Nan Y; Xiang Y; Shao J
J Int Med Res; 2019 Jan; 47(1):481-493. PubMed ID: 30556447
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
Matre P; Velez J; Jacamo R; Qi Y; Su X; Cai T; Chan SM; Lodi A; Sweeney SR; Ma H; Davis RE; Baran N; Haferlach T; Su X; Flores ER; Gonzalez D; Konoplev S; Samudio I; DiNardo C; Majeti R; Schimmer AD; Li W; Wang T; Tiziani S; Konopleva M
Oncotarget; 2016 Nov; 7(48):79722-79735. PubMed ID: 27806325
[TBL] [Abstract][Full Text] [Related]
11. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer.
Li HJ; Li X; Pang H; Pan JJ; Xie XJ; Chen W
Jpn J Clin Oncol; 2015 Nov; 45(11):1055-63. PubMed ID: 26373319
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing factor suppresses glioma progression by upregulation of long non-coding RNA-p21.
Yang J; Gan X; Tan B; Wang J; Chen Y
Life Sci; 2019 Jan; 216():92-100. PubMed ID: 29981322
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy.
Lukey MJ; Greene KS; Erickson JW; Wilson KF; Cerione RA
Nat Commun; 2016 Apr; 7():11321. PubMed ID: 27089238
[TBL] [Abstract][Full Text] [Related]
15. Aging Reduces an ERRalpha-Directed Mitochondrial Glutaminase Expression Suppressing Glutamine Anaplerosis and Osteogenic Differentiation of Mesenchymal Stem Cells.
Huang T; Liu R; Fu X; Yao D; Yang M; Liu Q; Lu WW; Wu C; Guan M
Stem Cells; 2017 Feb; 35(2):411-424. PubMed ID: 27501743
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway.
Li J; Li Y; Meng F; Fu L; Kong C
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30042171
[TBL] [Abstract][Full Text] [Related]
17. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
[TBL] [Abstract][Full Text] [Related]
18. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
Peng W; Wu J; Feng J
Clin Exp Med; 2017 Feb; 17(1):1-8. PubMed ID: 26475621
[TBL] [Abstract][Full Text] [Related]
19. LincRNA-p21 Impacts Prognosis in Resected Non-Small Cell Lung Cancer Patients through Angiogenesis Regulation.
Castellano JJ; Navarro A; Viñolas N; Marrades RM; Moises J; Cordeiro A; Saco A; Muñoz C; Fuster D; Molins L; Ramirez J; Monzo M
J Thorac Oncol; 2016 Dec; 11(12):2173-2182. PubMed ID: 27496652
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer.
Zhang J; Mao S; Guo Y; Wu Y; Yao X; Huang Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31196962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]